Adams ranks high on Deloitte list
Adams Respiratory Therapeutics ranked No. 7 in Deloitte & Touche’s Technology Fast 50 Program for New Jersey, a ranking of the 50 fastest growing technology, media, telecommunications and life sciences companies in the area, the company announced Monday.
“We are very proud to be recognized by Deloitte for achieving a revenue growth rate of 1,638 percent from 2002 to 2006,” commented Michael Valentino, chief executive officer of Adams, on the distinction. “It has been exhilarating to see the things we’ve done take hold. Our unique regulatory strategy for Mucinex coupled with our synergistic blend of consumer and professional marketing for the Mucinex brand helped fuel our phenomenal growth over the past five years. … We now market nine over-the-counter products with multiple new product introductions planned this fall. Additionally, we also plan to expand into the prescription respiratory market as early as 2008.”
LifeScan kicks off sweepstakes for blood glucose monitoring system
MILPITAS, Calif. LifeScan earlier this week kicked off its “What’s Your Color?” Giveaway, an online sweepstakes that offers entrants the chance to win one of 10,000 OneTouch UltraMini Blood Glucose Monitoring Systems in the color of their choice—limelight, pink glow, jet black, and the original color, silver moon.
“Many of my patients feel self-conscious about testing in public,” stated Steven Edelman, clinical professor at the University of California, San Diego, and founder of the non-profit organization Taking Control of Your Diabetes. “Having a cool, colorful, small device like the OneTouch UltraMini may help them be a little bit more open with their diabetes and allow them to test on a more regular basis.”
In addition to the new colored meters, 100 of the 10,000 winners will be selected at random to each receive an iPod nano, which will also be provided in the winner’s choice of color and engraved with a personalized message selected by the winner.
The iPod nanos will be pre-loaded with diabetes-related podcasts.
Natrol posts impressive sales increase
CHATSWORTH, Calif. Natrol on Wednesday posted a 17.8 percent increase over second-quarter 2006 sales to $19.5 million for the period ended June 30. Natrol attributed the sales increase to a strong performance from new products that offset a $900,000 decline out of the planned discontinuation of Ester-C.
“In addition to good financial results, we made excellent strategic progress with our business,” stated Wayne Bos, Natrol president and chief executive officer. “The acquisition of [Medical Research Institute] closed late in the quarter and further diversified our business. MRI provides not only a premium brand but contributes a strong, science-based pipeline for further penetration and market development of higher-growth areas of the nutraceutical business.”